BlackRock’s Immix Biopharma IMMX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $83.4K | Buy |
40,301
+28,477
| +241% | +$58.9K | ﹤0.01% | 4805 |
|
|
2025
Q1 | $19.9K | Sell |
11,824
-2,252
| -16% | -$3.78K | ﹤0.01% | 5046 |
|
|
2024
Q4 | $31K | Buy |
14,076
+73
| +0.5% | +$161 | ﹤0.01% | 4981 |
|
|
2024
Q3 | $20.9K | Buy |
14,003
+548
| +4% | +$817 | ﹤0.01% | 4880 |
|
|
2024
Q2 | $26.6K | Sell |
13,455
-5,866
| -30% | -$11.6K | ﹤0.01% | 4913 |
|
|
2024
Q1 | $59.3K | Buy |
19,321
+1,609
| +9% | +$4.94K | ﹤0.01% | 4776 |
|
|
2023
Q4 | $123K | Sell |
17,712
-279
| -2% | -$1.93K | ﹤0.01% | 4680 |
|
|
2023
Q3 | $61.5K | Buy |
17,991
+2,343
| +15% | +$8.01K | ﹤0.01% | 4899 |
|
|
2023
Q2 | $42.1K | Buy |
+15,648
| New | +$42.1K | ﹤0.01% | 5007 |
|
|
2022
Q2 | – | Sell |
-9,415
| Closed | -$22K | – | 5802 |
|
|
2022
Q1 | $22K | Buy |
+9,415
| New | +$22K | ﹤0.01% | 5468 |
|